The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals
Open accessAbstract
BACKGROUND: The SMART study was a trial of intermittent use of antiretroviral therapy (ART) (drug conservation [DC]) versus continuous use of ART (viral suppression [VS]) as a strategy to reduce toxicities, including cardiovascular disease (CVD) risk. We studied the predictive value of high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6) and D-dimer with CVD morbidity and mortality in HIV-infected patients who were enrolled in SMART beyond other measured CVD risk factors. METHODS: A blood sample was available in 5098 participants who were enrolled in the SMART study for the measurement of IL-6, hsCRP and D-dimer. Hazard ratios (HR) with 95% CI for CVD events were estimated for each quartile (Q) for each biomarker vs the 1(st) quartile and for 1 SD higher levels. For both treatment groups combined, unadjusted and adjusted HRs were determined using Cox regression models. RESULTS: There were 252 participants who had a CVD event over a median follow-up of 29 months. Adjusted HRs (95% CI) for CVD for Q4 vs Q1 were 4.65 (2.61, 8.29), 2.10 (1.40, 3.16), and 2.14 (1.38, 3.33) for IL-6, hsCRP and D-dimer, respectively. Associations were similar for the DC and VS treatment groups (interaction p-values were >0.30). The addition of the three biomarkers to a model that included baseline covariates significantly improved model fit (p<0.001). Area under the curve (AUC) estimates improved with inclusion of the three biomarkers in a model that included baseline covariates corresponding to other CVD risk factors and HIV factors (0.741 to 0.771; p<0.001 for difference). CONCLUSIONS: In HIV-infected individuals, IL-6, hsCRP and D-dimer are associated with an increased risk of CVD independent of other CVD risk factors. Further research is needed to determine whether these biomarkers can be used to improve CVD risk prediction among HIV positive individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Evaluating the Yield of Medical Tests
Harrell, F. E. (1982) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1982.03320430047030 · Cited by 3,490
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Regression analysis of multivariate incomplete failure time data by modeling marginal distributions
Wei, L. J., Lin, D. Y., & Weissfeld, L. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478873 · Cited by 1,868
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A., & Lundgren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
Self-citationMarkers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV Infection
Neuhaus, J., Jacobs, Jr., Baker, J. V., Calmy, A., Duprez, D., La Rosa, A., Kuller, L. H., Pett, S. L., Ristola, M., Ross, M. J., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/652749 · Cited by 869
Self-citationImproved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
Hogg, R. S. (1998) · JAMA · doi:10.1001/jama.279.6.450 · Cited by 850
Danesh, J., Kaptoge, S., Mann, A. G., Sarwar, N., Wood, A., Angleman, S. B., Wensley, F., Higgins, J. P. T., Lennon, L., Eiriksdottir, G., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050078 · Cited by 676
Currier, J. S., Lundgren, J. D., Carr, A., Klein, D., Sabin, C. A., Sax, P. E., Schouten, J. T., Smieja, M., & for Working Group 2 (2008) · Circulation · doi:10.1161/circulationaha.107.189624 · Cited by 368
Self-citationFibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis
Danesh, J., Whincup, P., Walker, M., Lennon, L., Thomson, A., Appleby, P., Rumley, A., & Lowe, G. D. O. (2001) · Circulation · doi:10.1161/01.cir.103.19.2323 · Cited by 344
Estimation of time‐dependent area under the ROC curve for long‐term risk prediction
Chambless, L. E., & Diao, G. (2006) · Statistics in Medicine · doi:10.1002/sim.2299 · Cited by 311
Evaluating the yield of medical tests
Harrell, F. E. (1982) · JAMA · doi:10.1001/jama.247.18.2543 · Cited by 310
Intertwining of thrombosis and inflammation in atherosclerosis
Croce, K., & Libby, P. (2007) · Current Opinion in Hematology · doi:10.1097/00062752-200701000-00011 · Cited by 284
Phillips, A. N., Carr, A., Neuhaus, J., Visnegarwala, F., Prineas, R., Burman, W. J., Williams, I., Drummond, F., Duprez, D., Belloso, W. H., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300215 · Cited by 240
Self-citationGrinspoon, S. K., Grunfeld, C., Kotler, D. P., Currier, J. S., Lundgren, J. D., Dubé, M. P., Lipshultz, S. E., Hsue, P. Y., Squires, K., Schambelan, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189622 · Cited by 231
Self-citationFord, E. S., Greenwald, J. H., Richterman, A. G., Rupert, A., Dutcher, L., Badralmaa, Y., Natarajan, V., Rehm, C., Hadigan, C., & Sereti, I. (2010) · AIDS · doi:10.1097/qad.0b013e32833ad914 · Cited by 195
D-dimer Correlates With Proinflammatory Cytokine Levels and Outcomes in Critically Ill Patients
Shorr, A. F., Thomas, S. J., Alkins, S. A., Fitzpatrick, T. M., & Ling, G. S. (2002) · Chest · doi:10.1378/chest.121.4.1262 · Cited by 193
Kreier, F., Kap, Y. S., Mettenleiter, T. C., van Heijningen, C., van der Vliet, J., Kalsbeek, A., Sauerwein, H. P., Fliers, E., Romijn, J. A., & Buijs, R. M. (2006) · Endocrinology · doi:10.1210/en.2005-0667 · Cited by 183
Hsue, P. Y., Hunt, P. W., Wu, Y., Schnell, A., Ho, J. E., Hatano, H., Xie, Y., Martin, J. N., Ganz, P., & Deeks, S. G. (2009) · AIDS · doi:10.1097/qad.0b013e32832e7140 · Cited by 167
Baker, J. V., Neuhaus, J., Duprez, D., Kuller, L. H., Tracy, R., Belloso, W. H., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., et al. (2011) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181f7f61a · Cited by 162
Self-citationRodger, A. J., Fox, Z., Lundgren, J. D., Kuller, L. H., Boesecke, C., Gey, D., Skoutelis, A., Goetz, M. B., Phillips, A. N., & the INSIGHT Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2009) · The Journal of Infectious Diseases · doi:10.1086/605447 · Cited by 160
Self-citationThe Coding Causes of Death in HIV (CoDe) Project
Kowalska, J. D., Friis‐Møller, N., Kirk, O., Bannister, W. P., Mocroft, A., Sabin, C. A., Reiss, P., Gill, M. J., Lewden, C., Phillips, A. N., et al. (2011) · Epidemiology · doi:10.1097/ede.0b013e31821b5332 · Cited by 142
Self-citationThe SMART Study Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-5-200809020-00003 · Cited by 135
Thrombosis and a Hypercoagulable State in HIV-Infected Patients
Shen, Y.-M. P., & Frenkel, E. P. (2004) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602960401000311 · Cited by 125
Cardiovascular disease in HIV infection
Palella, F. J., & Phair, J. (2011) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328347876c · Cited by 121
Cardiovascular manifestations of HIV infection
Ho, J. E., & Hsue, P. Y. (2009) · Heart · doi:10.1136/hrt.2008.161463 · Cited by 103
Blum, A., Hadas, V., Burke, M., Yust, I., & Kessler, A. (2005) · Clinical Cardiology · doi:10.1002/clc.4960280311 · Cited by 81
Biomarkers and HIV-associated cardiovascular disease
Baker, J. V., & Duprez, D. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed7ec · Cited by 80
Self-citationFolsom, A. R., Delaney, J. A., Lutsey, P. L., Zakai, N. A., Jenny, N. S., Polak, J. F., & Cushman, M. (2009) · American Journal of Hematology · doi:10.1002/ajh.21429 · Cited by 80
Cardiovascular implications from untreated human immunodeficiency virus infection
Baker, J. V., & Lundgren, J. D. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq483 · Cited by 75
Self-citationA new era of antiretroviral drug toxicity
Calmy, A., Hirschel, B. J., Cooper, D. A., & Carr, A. D. (2008) · Antiviral Therapy · doi:10.1177/135965350901400203 · Cited by 67
Soliman, E. Z., Prineas, R. J., Roediger, M. P., Duprez, D. A., Boccara, F., Boesecke, C., Stephan, C., Hodder, S., Stein, J. H., Lundgren, J. D., et al. (2010) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2010.10.027 · Cited by 65
Self-citationDevelopment of Diagnostic Criteria for Serious Non-AIDS Events in HIV Clinical Trials
Lifson, A. R., Belloso, W. H., Davey, R. T., Duprez, D. A., Gatell, J. M., Hoy, J., Krum, E. A., Nelson, R., Pedersen, C., Pérez, G. V., et al. (2010) · HIV Clinical Trials · doi:10.1310/hct1104-205 · Cited by 45
Self-citationBaker, J. V., Quick, H. H., Hullsiek, K. H., Tracy, R. P., Duprez, D. A., Henry, K., & Neaton, J. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2010.00835.x · Cited by 36
Self-citation
Cited by
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Self-citationSystemic Effects of Inflammation on Health during Chronic HIV Infection
Deeks, S. G., Tracy, R., & Douek, D. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.001 · Cited by 868
Self-citationNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784
Fletcher, C. V., Staskus, K., Wietgrefe, S. W., Rothenberger, M., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 664
Serrano-Villar, S., Sainz, T., Lee, S. A., Hunt, P. W., Sinclair, E., Shacklett, B. L., Ferre, A. L., Hayes, T. L., Somsouk, M., Hsue, P. Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004078 · Cited by 611
Metadata
- Authors
- Duprez, D. A., Neuhaus, J., Kuller, L. H., Tracy, R., Belloso, W., De Wit, S., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Nixon, D., Paton, N. I., Prineas, R. J., & James D. Neaton1 for the INSIGHT SMART Study Group
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-09-10
- Volume
- 7
- Issue
- 9
- Pages
- e44454
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2123354892
- Cited by
- 520
- References
- 40
- FWCI
- 51.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.